Alembic Pharmaceuticals Incorporates Wholly Owned Subsidiary in Dubai
Alembic Pharmaceuticals Ltd 路 Others (Uncategorized) 路 08 Sept 2026, 2:03 am
Alembic Pharmaceuticals Incorporates Wholly Owned Subsidiary in Dubai Alembic Pharmaceuticals has incorporated a wholly owned subsidiary, Alembic Pharmaceuticals Global FZCO, in Dubai, UAE, on 24th Aug'26. The entity has been established with a 100% shareholding via a cash subscription of AED 100,000, comprising 100 shares at AED 1,000 each. The new subsidiary will operate in the pharmaceutical sector, focusing on exploring new business opportunities alongside promoting, selling, and distributing the company's pharmaceutical products globally.
Original exchange filing (PDF)
More announcements from Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets, 15 mg and 45 mg. 路 15 Nov 2026
- Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026. 路 10 Nov 2026
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). 路 05 Nov 2026
- Please find attached Audio Recording of Investor Call. 路 05 Nov 2026
- Please find attached intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015. 路 04 Nov 2026
- Please find attached Press Release 路 04 Nov 2026
- Please find attached Investor Presentation for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
- Please find attached Press Release for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
